<DOC>
	<DOCNO>NCT00127153</DOCNO>
	<brief_summary>The purpose trial evaluate safety , tolerability , immunogenicity investigational pneumococcal vaccine healthy adult .</brief_summary>
	<brief_title>A Study V110 Pneumococcal Vaccine Healthy Adults ( V110-013 )</brief_title>
	<detailed_description />
	<mesh_term>Pneumococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Males female good health , age 2040 , history pneumococcal vaccination Subjects recent febrile illness Known suspect immune dysfunction , condition associate immunosuppression , receipt immunosuppressive chemotherapy , include longterm corticosteroid therapy</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>